Azithromycin Pharmacokinetics in Adults With Acute Respiratory Distress Syndrome Undergoing Treatment With Extracorporeal-Membrane Oxygenation

Abstract

Get full access to this article

View all access options for this article.

References

Wildschut

Ahsman

Allegaert

Mathot

Tibboel

. Determinants of drug absorption in different ECMO circuits. Intensive Care Med. 2010;36:2109-2116.

Shekar

Roberts

Ghassabian

. Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern? J Antimicrob Chemother. 2013;68:726-727.

Apotex Corp. Azithromycin [package insert]. Weston, FL: Apotex Corp; 2010.

Sevillano

Alou

Aguilar

Echevarria

Gimenez

Prieto

. Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum: an in vitro pharmacodynamic simulation. J Antimicrob Chemother. 2006;57:1128-1133.

Matznetter

Krasniqi

Kinsig

. Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy. Antimicrob Agents Chemother. 2013;57:1736-1742.